FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says

FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says

Source: 
Reuters
snippet: 

The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer (PFE.N) and French partner Valneva's (VLS.PA) trial of a Lyme disease vaccine candidate, the contract research firm said on Wednesday.